31 January 2013 To ASPREE participants and interested parties Recently you may have heard press reports that suggested aspirin might worsen an infrequent type of the eye disease called age – related macular degeneration or AMD. This is a condition of the eyes that in advanced cases causes severe vision loss. We write to reassure…Details
PRESS RELEASE Melbourne, January 23 2013 – Professor John McNeil, Head of Monash University’s Department of Epidemiology and Preventive Medicine and Lead Investigator of the ASPREE trial (pictured left) responds to the recent JAMA article study linking regular Aspirin Use and Age-Related Macular Degeneration (AMD): “The relationship between aspirin and AMD is complex and is…Details
Have you seen the ASPREE Community Service Announcement with Sir Gus Nossal? We are delighted to have the support of such a high profile and highly respected researcher.
ASPREE would like to sincerely thank Gus Nossal and Australian TV networks for airing this CSA.
New research published in the New England Journal of Medicine has found that aspirin may block the growth of colorectal tumours that were known to have a specific gene mutation. Researchers affiliated with the Harvard Medical School reported that aspirin was associated with a prolonged life of patients with tumours that carried the mutated PIK3CA…Details
Leading cancer expert says recent study adds further support for a randomised clinical trial of aspirin for cancer prevention. New research published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, showed regular aspirin may decrease the risk of ovarian cancer. Ovarian Cancer is the ninth most…Details
Humble hero or hidden villain? The ongoing story of aspirin’s powers. by Professor Andrew Tonkin The humble aspirin has a remarkable history dating back to ancient Egyptian times when the bark of weeping willow (which contains salicin from which the aspirin formulation is derived) was found to have anti-inflammatory properties. And Hippocrates wrote about the…Details
Senior ASPREE investigator, Professor Mark Nelson says a recent paper that links taking NSAID (Non Steroidal Anti-inflammatory Drugs) to a decrease in the risk of developing skin cancer underscores the importance of the ASPREE study. “We welcome the findings of this study as the possibility of aspirin having cancer preventing properties is one of the rationales…Details
Popular morning radio personalities Ross and John on Melbourne radio station 3AW, interviewed Prof Andrew Tonkin, ASPREE senior investigator and Head of Cardiovascular Research Unit, Monash University about aspirin and the ASPREE trial. Hear Andrew discuss the pros and cons of aspirin and what the ASPREE study is really about. Click here to listen (run time…Details
Recently published research suggesting aspirin could be used to combat cancer only reinforces the need for more in depth analysis, one of the world’s foremost aspirin experts has said. Principal Investigator to ASPREE (ASPirin in Reducing Events in the Elderly) Professor John McNeil said the research, conducted by a team at the University of Oxford…Details
Research findings by Rothwell et al, (two in ‘The Lancet’ and one in ‘The Lancet Oncology’) to hit the media today are suggesting that daily aspirin can be used to help prevent and possibly treat cancer. Professor John McNeil, Principal Investigator of the ASPREE study in Australia puts these papers in context: The new research…Details